| Primary |
| Drug Use For Unknown Indication |
28.1% |
| Oral Candidiasis |
15.7% |
| Product Used For Unknown Indication |
12.4% |
| Oral Fungal Infection |
5.2% |
| Fungal Infection |
4.4% |
| Hypertension |
4.4% |
| Tinea Pedis |
4.4% |
| Erythema |
2.8% |
| Ill-defined Disorder |
2.8% |
| Mouth Ulceration |
2.8% |
| Atrial Fibrillation |
2.0% |
| Candidiasis |
2.0% |
| Fungal Skin Infection |
2.0% |
| Aphthous Stomatitis |
1.6% |
| Hypercholesterolaemia |
1.6% |
| Hypertensive Heart Disease |
1.6% |
| Mycosis Fungoides |
1.6% |
| Respiratory Tract Infection |
1.6% |
| Type 2 Diabetes Mellitus |
1.6% |
| Anxiety |
1.2% |
|
| International Normalised Ratio Increased |
34.0% |
| Medication Error |
6.4% |
| Drug Interaction |
5.3% |
| Dyspnoea |
4.3% |
| Haemorrhage |
4.3% |
| Intentional Drug Misuse |
4.3% |
| Motor Dysfunction |
4.3% |
| Respiratory Arrest |
4.3% |
| Gingival Bleeding |
3.2% |
| Oedema Mouth |
3.2% |
| Oedema Peripheral |
3.2% |
| Scar |
3.2% |
| Ultrasound Antenatal Screen Abnormal |
3.2% |
| Vomiting |
3.2% |
| Wrong Drug Administered |
3.2% |
| Haematoma |
2.1% |
| Henoch-schonlein Purpura |
2.1% |
| Mouth Haemorrhage |
2.1% |
| Overdose |
2.1% |
| Priapism |
2.1% |
|
| Secondary |
| Drug Use For Unknown Indication |
24.2% |
| Product Used For Unknown Indication |
20.9% |
| Oral Candidiasis |
10.6% |
| Fungal Infection |
7.6% |
| Oral Fungal Infection |
6.3% |
| Erythema |
5.0% |
| Tinea Pedis |
3.6% |
| Cellulitis |
2.6% |
| Ill-defined Disorder |
2.3% |
| Nodule |
2.0% |
| Papule |
2.0% |
| Fungal Skin Infection |
1.7% |
| Rash |
1.7% |
| Vulvovaginal Mycotic Infection |
1.7% |
| Aphthous Stomatitis |
1.3% |
| Atrial Fibrillation |
1.3% |
| Candidiasis |
1.3% |
| Mouth Ulceration |
1.3% |
| Mycosis Fungoides |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
|
| International Normalised Ratio Increased |
32.0% |
| Medication Error |
6.2% |
| Ocular Myasthenia |
6.2% |
| Drug Interaction |
5.2% |
| Oedema Mouth |
5.2% |
| Swollen Tongue |
5.2% |
| Henoch-schonlein Purpura |
4.1% |
| Motor Dysfunction |
4.1% |
| Respiratory Arrest |
4.1% |
| Gingival Bleeding |
3.1% |
| Rhinosporidiosis |
3.1% |
| Scar |
3.1% |
| Vomiting |
3.1% |
| Wrong Drug Administered |
3.1% |
| Abortion |
2.1% |
| Dyspnoea |
2.1% |
| Fungal Infection |
2.1% |
| Lichen Sclerosus |
2.1% |
| Mouth Haemorrhage |
2.1% |
| Oedema Peripheral |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
20.7% |
| Product Used For Unknown Indication |
19.2% |
| Unevaluable Event |
9.4% |
| Rash |
4.6% |
| Chest Pain |
4.2% |
| Hiv Infection |
4.2% |
| Acne |
3.8% |
| Anxiety |
3.8% |
| Dermatitis |
3.8% |
| Pyelonephritis Acute |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Non-small Cell Lung Cancer |
3.1% |
| Premedication |
2.5% |
| Prophylaxis Of Nausea And Vomiting |
2.3% |
| Neuralgia |
2.1% |
| Pain |
2.1% |
| Pneumonia |
2.1% |
| Acute Myeloid Leukaemia |
1.9% |
| Mucosal Inflammation |
1.9% |
| Prophylaxis |
1.9% |
|
| Septic Shock |
16.1% |
| Stevens-johnson Syndrome |
14.5% |
| Abscess Limb |
6.5% |
| Staphylococcal Sepsis |
6.5% |
| Pneumonia Aspiration |
4.8% |
| Respiratory Failure |
4.8% |
| Tooth Loss |
4.8% |
| Venipuncture Site Inflammation |
4.8% |
| Convulsion |
3.2% |
| Necrotising Fasciitis |
3.2% |
| Neutropenia |
3.2% |
| Psychomotor Retardation |
3.2% |
| Renal Failure Acute |
3.2% |
| Tachycardia |
3.2% |
| Thrombocytopenia |
3.2% |
| Tongue Coated |
3.2% |
| Urine Flow Decreased |
3.2% |
| Vaginal Ulceration |
3.2% |
| Venous Pressure Increased |
3.2% |
| Bicytopenia |
1.6% |
|
| Interacting |
| Product Used For Unknown Indication |
73.1% |
| Oral Fungal Infection |
26.9% |
|
| Ocular Myasthenia |
71.4% |
| Myasthenia Gravis |
14.3% |
| Swollen Tongue |
14.3% |
|
